EXL — Elixinol Wellness Cashflow Statement
0.000.00%
Last trade - 00:00- AU$4.86m
- AU$5.73m
- AU$14.99m
Annual cashflow statement for Elixinol Wellness, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.465 | 0.405 | 0.386 | 1.56 | 0.103 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -22.6 | -14.1 | -8.15 | -2.76 | -3.47 |
| Capital Expenditures | -0.328 | -0.292 | -0.012 | -0.017 | -0.06 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2.88 | 0.464 | -0.857 | -1.03 | -0.006 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2.55 | 0.172 | -0.869 | -1.04 | -0.066 |
| Financing Cash Flow Items | -2.52 | -0.11 | 0 | -0.199 | -0.564 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 27.5 | -1.16 | -0.757 | 1.61 | 3.92 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.37 | -15.1 | -9.79 | -2.16 | 0.37 |